Horizon Therapeutics shares owned by Farallon Capital Management
Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Farallon Capital Management
from 13F filings
Historical chart of Farallon Capital Management investment in Horizon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Horizon Therapeutics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Horizon Therapeutics by Farallon Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $770M | 6.7M | 115.69 |
2023-06-30 | $712M | 6.9M | 102.85 |
2023-03-31 | $592M | 5.4M | 109.14 |
2022-12-31 | $421M | 3.7M | 113.80 |
2022-09-30 | $110M | 1.8M | 61.89 |
2022-06-30 | $0 | 1.1M | 0.00 |
2022-03-31 | $156M | 1.5M | 105.21 |
2021-12-31 | $151M | 1.4M | 107.76 |
2021-09-30 | $128M | 1.2M | 109.54 |
2021-06-30 | $47M | 500k | 93.64 |
2020-09-30 | $12M | 150k | 77.68 |
More positions owned by Farallon Capital Management
View all positions for Farallon Capital Management
Top funds holding Horizon Therapeutics
View all funds holding Horizon Therapeutics